AMERIPRISE FINANCIAL INC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$891,000
-40.0%
22,626
-45.0%
0.00%
-100.0%
Q3 2022$1,485,000
-4.6%
41,144
-19.6%
0.00%0.0%
Q2 2022$1,557,000
-12.1%
51,176
-11.7%
0.00%0.0%
Q1 2022$1,771,000
-2.8%
57,932
-0.7%
0.00%0.0%
Q4 2021$1,822,000
+709.8%
58,321
+296.7%
0.00%
Q3 2021$225,00014,7000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders